Clearpoint Neuro is trading at $9.31, down 5.1%, with CPI-driven market pressure the most likely explanation. - No new company-specific announcement was identified for October 14, 2026; supplied price history shows several weaker closes, but available evidence does not establish a company-specific trigger. - Reuters reported September headline CPI at 3.7% versus 3.6% expected and core CPI at 2.6% versus 2.5%; stocks fell as Treasury yields rose and rate-hike expectations strengthened. - Healthcare’s reported gains make a sector-wide explanation less persuasive.